The activity of endothelial NO synthase (eNOS) is triggered by calmodulin (CaM) binding and is often further regulated by phosphorylation at several positions in the enzyme. Phosphorylation at Ser 1179 occurs in response to diverse physiologic stimuli and increases the NO synthesis and cytochrome c reductase activities of eNOS, thereby enhancing its participation in biological signal cascades. Despite its importance, the mechanism by which Ser 1179 phosphorylation increases eNOS activity is not understood. To address this, we used stopped-flow spectroscopy and computer modeling approaches to determine how the phosphomimetic mutation (S1179D) may impact electron flux through eNOS and the conformational behaviors of its reductase domain, both in the absence and presence of bound CaM. We found that S1179D substitution in CaM-free eNOS had multiple effects; it increased the rate of flavin reduction, altered the conformational equilibrium of the reductase domain, and increased the rate of its conformational transitions. We found these changes were equivalent in degree to those caused by CaM binding to wild-type eNOS, and the S1179D substitution together with CaM binding caused even greater changes in these parameters. The modeling indicated that the changes caused by the S1179D substitution, despite being restricted to the reductase domain, are sufficient to explain the stimulation of both the cytochrome c reductase and NO synthase activities of eNOS. This helps clarify how Ser 1179 phosphorylation regulates eNOS and provides a foundation to compare its regulation by other phosphorylation events.Nitric oxide (NO) synthase enzymes (EC 1.14.13.39) are homodimers with subunits composed of an N-terminal oxygenase domain (NOSoxy) 4 that is linked to a C-terminal reductase domain (NOSr) by an intervening calmodulin (CaM) binding sequence (1-4). Many of the structural and catalytic features of NOSr are shared among a family of eukaryotic dual-flavin enzymes whose members include cytochrome P450 reductase, methionine synthase reductase, and novel reductase-1 (5-7). These enzymes are all composed of an FMN-binding domain that is attached to a FAD/NADPH-binding domain (ferredoxin NADP ϩ -reductase (FNR)) by a flexible hinge of various lengths (8 -10). Their electron transfer (ET) reactions all involve a hydride transfer from NADPH to the FAD cofactor bound within the FNR domain, which then passes electrons sequentially to the FMN domain. Once the FMN domain receives two electrons, its FMN hydroquinone (FMNhq) can transfer an electron to a heme group that is located either within the enzyme itself (i.e. NOS), in a partner hemeprotein acceptor (i.e. cytochrome P450 reductase), or in a non-native hemeprotein acceptor such as cytochrome c (6,(11)(12)(13)(14). Importantly, ET through diflavin enzymes relies on the transient interactions and motions of the FMN domain, which must move between an FNR-bound, conformationally closed "input" state and an unbound, conformationally open "output" state (15-17). We and others have proposed...